LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.88
-2.06 (-6.45%)
At close: Nov 25, 2025, 4:00 PM EST
29.95
+0.07 (0.23%)
After-hours: Nov 25, 2025, 6:08 PM EST

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21
935794---
Enterprise Value
734578---
Last Close Price
31.9428.87---
PB Ratio
4.713.89---
P/TBV Ratio
4.823.89---
Debt / Equity Ratio
0.010.010.010.01-
Asset Turnover
0.08--0.46-
Quick Ratio
12.4620.093.554.6814.61
Current Ratio
12.6920.363.634.9114.62
Return on Equity (ROE)
-28.78%-38.94%-157.61%-39.80%-
Return on Assets (ROA)
-19.52%-25.64%-77.17%-20.07%-
Return on Capital (ROIC)
-20.61%-28.47%-101.31%-24.01%-
Return on Capital Employed (ROCE)
-34.90%-28.60%-139.70%-28.00%-39.20%
Earnings Yield
-6.30%-6.27%---
FCF Yield
-4.94%-7.54%---
Buyback Yield / Dilution
-87.55%-986.27%79.28%-1.05%-
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q